GenomOncology Precision Oncology

by GenomOncology  · Based in United States → — Precision Decisions
Hematology Oncology Pathology

Overview

GenomOncology transforms complex and fragmented oncology data into actionable intelligence. The platform merges all assay and lab data into one report to increase operational efficiency, delivers transparent and explainable AI that generates real-time, auto-generated data interpretations at the point of care, automates and customizes patient treatment with unparalleled clinical trial matching, and connects seamlessly with LIS, LIMS, and EHR for automated, bidirectional data exchange. Oncology professionals face an unprecedented challenge with over 1,400 FDA indications and 15,000 active clinical trials, making clear decision-making difficult. GenomOncology’s platform aims to be the core infrastructure that unifies data, workflows, and insights across cancer care, serving as an embedded intelligence layer within oncology ecosystems.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated Somatic & Germline Variant Interpretation
  • Clinical Trial Matching & Decision Support
  • Custom Molecular Pathology Reporting (HL7, PDF, XML, DOCX, TXT)
  • Data Extraction from Unstructured Documents (igniteIQ)
  • Genomic Data Visualization and Analytics (GenomAnalytics)
  • Molecular Tumor Board Workflow
  • Comprehensive API Suite for System Integration
  • Secure & Scalable Infrastructure
  • Transparent, Explainable AI
  • Real-time, auto-generated data interpretations

Use Cases

  • Accelerate reporting and eliminate bottlenecks for molecular pathologists/lab techs
  • Never miss a clinical trial opportunity for patients with real-time trial matching for oncologists/clinical trial professionals
  • Unlock the power of oncology data with automated extraction and normalization for bioinformaticians/clinical researchers
  • Automating genomic reporting into the EHR
  • Standardizing genomic variant interpretation and classification
  • Facilitating molecular tumor board review

What Physicians Need to Know

Evidence Base
GenomOncology's platform leverages a comprehensive knowledge base that includes FDA/EMA approved and investigational oncology agents, NCCN guidelines, and other precision oncology databases like OncoKB and CIViC. The evidence base incorporates drugs' mechanism of action, molecular target, modality, and other characteristics. It also includes extensive synonym lists and database codes from sources like NCIt, JAX-CKB, OncoTree, SNOMED, ICD-9/10, and FDA. The platform also integrates literature references via PubMed.
Literature Scope
The platform's drug ontology is expertly curated and continuously maintained, including information from databases, prescribing labels, guidelines, and publications. It supports both USA and EU therapies. The knowledge base covers over 1,400 FDA indications and more than 15,000 active clinical trials.
Clinical Validation Studies
GenomOncology's Pathology Workbench features an automated variant interpretation algorithm that has achieved a 95% concordance rate with manual interpretations. Case studies highlight the platform's ability to streamline variant analysis, validation, and support for assays like TruSight Oncology 500, enhancing precision medicine programs. One case study demonstrated that without the Pathology Workbench, two targetable variants might not have been identified, reducing the chances of a patient knowing about a matched clinical trial. The platform has been tested for clinical utility within the Johns Hopkins Molecular Tumor Board and in community settings.
Alert Fatigue Management
GenomOncology offers configurable notification preferences and allows clinicians to customize the cadence, type, and form of communication they receive. This aims to streamline cohort identification, in-house clinical trial matching, and knowledge monitoring, helping to manage the volume and complexity of new genetic discoveries and treatment options. While not explicitly detailing alert fatigue *reduction strategies* within the tool, the customization options suggest an approach to make alerts more relevant and manageable.
Drug Interaction Checking
While GenomOncology's primary focus is on genomic data interpretation and clinical trial matching, the importance of drug-drug interactions in precision oncology is recognized in the broader context of precision medicine. The platform's comprehensive drug ontology and its ability to integrate various data sources could potentially support future drug interaction checking capabilities, though this is not explicitly detailed as a current feature.
Differential Diagnosis Support
GenomOncology's tools focus on matching genomic alterations to targeted therapies and clinical trials, rather than providing differential diagnosis support. The platform helps identify actionable somatic mutations and corresponding drug targets based on the mutational profile of a tumor.
Guideline Update Frequency
The clinical trial database, containing approximately 10,000 trials with structured eligibility criteria, is updated on a nightly basis by ingesting data from clinicaltrials.gov. The in-house content and curation team continuously maintains the drug ontology and all related elements. Therapeutic information, including FDA approvals and special statuses, is also regularly updated. Annotation sets are validated quarterly.
Clinical Workflow Integration
GenomOncology's solutions are designed for seamless integration into clinical workflows. The GO API Suite enables bidirectional data flow with any LIS, EHR, or LIMS, using standards-based HL7, FHIR, and REST connectivity. The Pathology Workbench integrates directly with lab sequencers to annotate variants, match trials and therapies, and create comprehensive reports that can be integrated back into a patient's record. The platform supports flexible deployment options, including cloud, on-premise, or hybrid environments.
Decision Audit Trail
The platform's solutions deliver transparent, explainable AI that generates real-time, auto-generated data interpretations. This transparency, combined with the ability to capture treatment recommendations from molecular tumor board conferences, suggests a mechanism for tracking and auditing decisions, though a specific 'decision audit trail' feature is not explicitly detailed.
Physician Tip

GenomOncology's platform excels in providing up-to-date, evidence-based insights for precision oncology, particularly in genomic variant interpretation and clinical trial matching. Leverage the comprehensive knowledge base and real-time updates to identify relevant therapies and trials. The customizable reporting and workflow integration can streamline your practice, but be mindful of configuring alerts to avoid fatigue. While strong in genomic-driven treatment decisions, consider integrating with other tools for comprehensive drug interaction checking and differential diagnosis support.

GenomOncology's platform is highly adaptable, offering seamless integration with existing LIS, LIMS, and EHR systems through its API Suite, supporting HL7, FHIR, and REST connectivity. It can be deployed in cloud, on-premise, or hybrid environments, providing flexibility for various institutional IT infrastructures. The Pathology Workbench directly integrates with lab sequencers for an end-to-end workflow from sequencing to reporting. Customization options allow for prioritization of institutional trials and tailoring report outputs to specific clinical and reimbursement requirements.

Details

Category Clinical Decision Support & Reference, Oncology AI, Pathology AI
Pricing Unknown
DeploymentCloud, On-premise, Hybrid
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Unknown
Integrations
EHR Not specified
Specialties Hematology, Oncology, Pathology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate GenomOncology Precision Oncology

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for GenomOncology Precision Oncology.

View all on YouTube

Frequently Asked Questions

GenomOncology's Precision Oncology Platform (POP) provides data-driven insights by transforming complex genomic and clinical data into actionable information. It helps streamline decision-making by offering tools for molecular pathology, clinical trial optimization, and therapy selection, integrating directly into existing workflows.
For oncologists, the platform offers real-time, biomarker-specific clinical trial matching, helping to identify suitable trials and avoid missed opportunities. It also provides decision support for cancer diagnosis, treatment, and management by leveraging medical data, clinical guidelines, and computational algorithms.
GenomOncology's platform is designed with enterprise-grade security and HIPAA compliance, and it adheres to CAP guidelines. It integrates with existing security infrastructures and offers user roles and permissions to ensure data integrity and patient privacy.
Several other precision oncology decision support tools exist, including MyCancerGenome and OncoKB, which are noted for their comprehensive and up-to-date information on somatic mutations. Other platforms like Tempus One and CureMatch also offer AI-driven insights and personalized treatment recommendations.
GenomOncology's pricing is not publicly disclosed and is structured for enterprise-level healthcare institutions and molecular laboratories. It is generally not transparent, and interested parties need to contact the company for a demo and quote.
Potential limitations include a likely high cost due to its enterprise focus and a steep learning curve for non-specialized users given the complexity of the domain and features. Significant implementation and integration effort may also be required to connect with existing hospital/lab infrastructure.
GenomOncology's GO API Suite enables bidirectional data flow with any LIS, EHR, or LIMS, utilizing standards-based HL7, FHIR, and REST connectivity. This allows for seamless integration and automation of genomic reporting into the EHR.

Related Tools

a2z Radiology AI Inc.
a2z Radiology AI Inc.
Clinical Decision Support & Reference
Abdo-Triage is an AI tool by a2z Radiology AI Inc. designed to assist radiologists in triaging abdominal imaging studies and identifying critical findings.
OpenAI
OpenAI
Clinical Decision Support & Reference
ChatGPT for Clinicians by OpenAI provides advanced AI capabilities to assist medical professionals with information synthesis, documentation, and patient communication.
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI
Clinical Decision Support & Reference
The Claire OCT System by Perimeter Medical Imaging AI uses Optical Coherence Tomography and AI to provide real-time, high-resolution tissue imaging during surgery to help identify cancerous tissue.
Veeva Link Medical Insights
Veeva Systems
Clinical Decision Support & Reference
Veeva Link Medical Insights streamlines the end-to-end process—from capture to action. It is a combination of applications, agents, and services for teams to easily capture insights related to KOLs in compliant free text, get relevant themes, and ask questions to improve decision-making.
Semantic Clinical Artificial Intelligence (SCAI)
University at Buffalo (UB)
Clinical Decision Support & Reference
Semantic Clinical Artificial Intelligence (SCAI) is a clinical AI tool developed by University at Buffalo researchers that can respond to medical questions, demonstrating high accuracy on medical licensing exams and augmenting physician decision-making.
Prenaital
Prenaital
Clinical Decision Support & Reference
Prenaital uses AI to detect and manage high-risk pregnancies, enhancing the detection of conditions like abnormal fetal growth, preterm birth, and stillbirth.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-08-23 | First Added: 2026-08-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.